SHREE GANESH REMEDIES
Back to Balance Sheet
|
SHREE GANESH REMEDIES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2020 | Mar2019 | |
|---|---|---|---|---|
| Total Current Liabilities | ₹24 Cr | ₹26 Cr | ₹10 Cr | ₹6.79 Cr |
What is the latest Total Current Liabilities ratio of SHREE GANESH REMEDIES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹24 Cr |
| Mar2024 | ₹26 Cr |
| Mar2020 | ₹10 Cr |
| Mar2019 | ₹6.79 Cr |
How is Total Current Liabilities of SHREE GANESH REMEDIES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹24 Cr | -6.65 | |
| Mar2024 | ₹26 Cr | 149.96 | |
| Mar2020 | ₹10 Cr | 52.89 | |
| Mar2019 | ₹6.79 Cr | - | |
Compare Total Current Liabilities of peers of SHREE GANESH REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHREE GANESH REMEDIES | ₹514.9 Cr | -0.2% | -8.1% | -43.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹386,329.0 Cr | -0.2% | -6.3% | -8.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹164,674.0 Cr | 3.3% | -3.4% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹133,891.0 Cr | -0.7% | 3.8% | 26.3% | Stock Analytics | |
| CIPLA | ₹107,292.0 Cr | -3% | -11.8% | -8.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,184.0 Cr | 6% | -3.5% | -4.3% | Stock Analytics | |
SHREE GANESH REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHREE GANESH REMEDIES | -0.2% |
-8.1% |
-43.7% |
| SENSEX | 0.2% |
-3.6% |
8.6% |
You may also like the below Video Courses